Cynata Therapeutics Limited (FRA:51S)

Cynata Therapeutics Ratios and Metrics

Market cap in millions EUR. Fiscal year is July - June.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Nov 26, 2025	Jun 30, 2025	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021
Market Capitalization	35	19	33	14	34	46
Market Cap Growth	28.22%	-42.66%	141.05%	-59.73%	-25.70%	4.38%
Enterprise Value	32	13	26	4	16	30
Last Close Price	0.11	0.06	0.15	0.05	0.22	0.27
PS Ratio	33.06	17.98	22.88	13.57	6.64	46.80
PB Ratio	10.42	5.67	7.34	1.34	2.15	2.55
P/TBV Ratio	10.42	5.67	7.34	1.34	2.15	2.55
EV/Sales Ratio	30.07	12.41	18.06	3.65	3.19	30.68
Asset Turnover	0.24	0.24	0.17	0.07	0.28	0.07
Quick Ratio	4.24	4.24	5.39	7.30	9.23	16.71
Current Ratio	4.40	4.40	5.58	7.46	9.33	17.03
Return on Equity (ROE)	-142.29%	-142.29%	-81.37%	-70.17%	-20.81%	-34.05%
Return on Assets (ROA)	-77.08%	-77.08%	-46.70%	-40.86%	-13.42%	-19.85%
Return on Capital (ROIC)	-91.02%	-91.02%	-53.39%	-45.73%	-14.49%	-20.85%
Return on Capital Employed (ROCE)	-160.70%	-160.70%	-141.70%	-89.00%	-25.30%	-26.60%
Earnings Yield	-15.07%	-27.71%	-18.39%	-63.59%	-10.56%	-10.63%
Buyback Yield / Dilution	-14.10%	-14.09%	-23.80%	-1.27%	-9.85%	-24.80%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.